pyrroles has been researched along with Hyperammonemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, WY; Hung, IF; Mok, MY; Shea, YF; Yau, CC | 1 |
| Davis, MP; Sharma, P; Shinde, SS | 1 |
| Hara, K; Hijioka, S; Kawai, H; Kondo, S; Matsumoto, K; Mizuno, N; Niwa, Y; Sawaki, A; Tajika, M; Yamao, K | 1 |
| Kwak, JY; Lee, NR; Song, EK; Yhim, HY; Yim, CY | 1 |
1 trial(s) available for pyrroles and Hyperammonemia
| Article | Year |
|---|---|
Clinical efficacy and safety of sunitinib after imatinib failure in Japanese patients with gastrointestinal stromal tumor.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Gastrointestinal Stromal Tumors; Humans; Hyperammonemia; Imatinib Mesylate; Indoles; Japan; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Portography; Pyrimidines; Pyrroles; Remission Induction; Retrospective Studies; Sunitinib; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2011 |
3 other study(ies) available for pyrroles and Hyperammonemia
| Article | Year |
|---|---|
Sunitinib-induced hyperammonaemia in a patient with pancreatic neuroendocrine tumour.
Topics: Humans; Hyperammonemia; Indoles; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sunitinib | 2013 |
Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy.
Topics: Antineoplastic Agents; Arginine; Brain Diseases, Metabolic; Carcinoma, Hepatocellular; Humans; Hyperammonemia; Indoles; Liver Neoplasms; Male; Pyrroles; Sunitinib; Young Adult | 2014 |
Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.
Topics: Aged; Antineoplastic Agents; Brain Diseases, Metabolic; Confusion; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hyperammonemia; Indoles; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Sunitinib; Treatment Outcome | 2011 |